These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37235572)

  • 21. Establishment and implementation of Cancer Genomic Medicine in Japan.
    Mukai Y; Ueno H
    Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.
    Rodriguez-Rodriguez L; Hirshfield KM; Rojas V; DiPaola RS; Gibbon D; Hellmann M; Isani S; Leiser A; Riedlinger GM; Wagreich A; Ali SM; Elvin JA; Miller VA; Ganesan S
    Gynecol Oncol; 2016 Apr; 141(1):2-9. PubMed ID: 27016222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling.
    Madison R; Schrock AB; Castellanos E; Gregg JP; Snider J; Ali SM; Miller VA; Singal G; Alexander BM; Venstrom JM; Chung JH
    Lung Cancer; 2020 Oct; 148():69-78. PubMed ID: 32823229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Handling of Germline Findings in Clinical Comprehensive Cancer Genomic Profiling.
    Okazawa-Sakai M; Yamamoto Y; Futagawa M; Okamura M; Miyawaki S; Nishina T; Takehara K; Kozuki T; Tomida S; Hyodo I; Ohsumi S; Hirasawa A
    Acta Med Okayama; 2022 Dec; 76(6):673-678. PubMed ID: 36549769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient survey on cancer genomic medicine in Japan under the national health insurance system.
    Kage H; Akiyama N; Chang H; Shinozaki-Ushiku A; Ka M; Kawata J; Muto M; Okuma Y; Okita N; Tsuchihara K; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Yachida S; Hirasawa A; Kubo M; Kenmotsu H; Tanabe M; Ushiku T; Muto K; Seto Y; Oda K
    Cancer Sci; 2024 Mar; 115(3):954-962. PubMed ID: 38273803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan.
    Kage H; Shinozaki-Ushiku A; Ishigaki K; Sato Y; Tanabe M; Tanaka S; Tanikawa M; Watanabe K; Kato S; Akagi K; Uchino K; Mitani K; Takahashi S; Miura Y; Ikeda S; Kojima Y; Watanabe K; Mochizuki H; Yamaguchi H; Kawazoe Y; Kashiwabara K; Kohsaka S; Tatsuno K; Ushiku T; Ohe K; Yatomi Y; Seto Y; Aburatani H; Mano H; Miyagawa K; Oda K
    Cancer Sci; 2023 Apr; 114(4):1710-1717. PubMed ID: 36601953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers.
    Bajwah S; Oluyase AO; Yi D; Gao W; Evans CJ; Grande G; Todd C; Costantini M; Murtagh FE; Higginson IJ
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012780. PubMed ID: 32996586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological distress, social support, and family satisfaction among family members of non-COVID-19 critical care patients: A cross-sectional study.
    Padilla-Fortunatti C; Munro CL; Gattamorta K
    J Nurs Scholarsh; 2023 Jan; 55(1):33-44. PubMed ID: 36173259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive genomic profiling for patients with chemotherapy-naïve advanced cancer.
    Kondo T; Matsubara J; Quy PN; Fukuyama K; Nomura M; Funakoshi T; Doi K; Sakamori Y; Yoshioka M; Yokoyama A; Tamaoki M; Kou T; Hirohashi K; Yamada A; Yamamoto Y; Minamiguchi S; Nishigaki M; Yamada T; Kanai M; Matsumoto S; Muto M
    Cancer Sci; 2021 Jan; 112(1):296-304. PubMed ID: 33007138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current Status and Prospects of the Comprehensive Cancer Genome Profiling].
    Imoto I; Fukue M; Takaiso N
    Gan To Kagaku Ryoho; 2021 Jan; 48(1):7-11. PubMed ID: 33468714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Questionnaire Survey on the Timing of Comprehensive Genomic Profiling for Advanced Recurrent Colorectal Cancer and Its Impact on Patients].
    Yarimizu A; Kuribayashi M; Nomura K; Kimura K; Takenaka Y; Song J; Ohashi E; Nishimura Y; Demachi T; Hirata M; Beppu N; Uchino M; Ikeuchi H; Ikeda M; Kataoka K
    Gan To Kagaku Ryoho; 2023 Aug; 50(8):891-893. PubMed ID: 37608415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal study of symptom burden in outpatients with advanced cancers based on electronic Patient-Reported Outcome (ePRO) platform: a single institution, prospective study protocol.
    Tang L; Pang Y; He Y; Shi Q; Han X; Li Z; Zhou C; Zhou Y; He S; Wang Y; Zhang Y; Song L; Wang B; Li X
    BMJ Open; 2020 Nov; 10(11):e038223. PubMed ID: 33444183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418).
    Mascarenhas E; Gelatti AC; Araújo LH; Baldotto C; Mathias C; Zukin M; Werutsky G; Pacheco P; Gomes R; de Castro G; Cordeiro de Lima VC
    Thorac Cancer; 2021 Mar; 12(5):580-587. PubMed ID: 33314759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review.
    van Schaik LF; Engelhardt EG; Wilthagen EA; Steeghs N; Fernández Coves A; Joore MA; van Harten WH; Retèl VP
    Crit Rev Oncol Hematol; 2024 Oct; 202():104441. PubMed ID: 39002790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
    Singal G; Miller PG; Agarwala V; Li G; Kaushik G; Backenroth D; Gossai A; Frampton GM; Torres AZ; Lehnert EM; Bourque D; O'Connell C; Bowser B; Caron T; Baydur E; Seidl-Rathkopf K; Ivanov I; Alpha-Cobb G; Guria A; He J; Frank S; Nunnally AC; Bailey M; Jaskiw A; Feuchtbaum D; Nussbaum N; Abernethy AP; Miller VA
    JAMA; 2019 Apr; 321(14):1391-1399. PubMed ID: 30964529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare system.
    Perdrizet K; Stockley TL; Law JH; Smith A; Zhang T; Fernandes R; Shabir M; Sabatini P; Youssef NA; Ishu C; Li JJ; Tsao MS; Pal P; Cabanero M; Schwock J; Ko HM; Boerner S; Ruff H; Shepherd FA; Bradbury PA; Liu G; Sacher AG; Leighl NB
    Cancer Treat Res Commun; 2022; 31():100534. PubMed ID: 35278845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronological improvement in precision oncology implementation in Japan.
    Sunami K; Naito Y; Komine K; Amano T; Ennishi D; Imai M; Kage H; Kanai M; Kenmotsu H; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Saigusa Y; Yoshino T
    Cancer Sci; 2022 Nov; 113(11):3995-4000. PubMed ID: 35976133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use.
    Proudman D; DeVito NC; Belinson S; Allo MA; Morris ED; Signorovitch J; Patel AK
    J Med Econ; 2022; 25(1):817-825. PubMed ID: 35593483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budget Impact Analysis of Comprehensive Genomic Profiling in Advanced Non-Small Cell Lung Cancer in Taiwan.
    Tsai YL; Chang CJ
    Value Health Reg Issues; 2023 May; 35():48-56. PubMed ID: 36863067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unlocking Access to Broad Molecular Profiling: Benefits, Barriers, and Policy Solutions.
    Thomas DM; Hackett JM; Plestina S
    Public Health Genomics; 2021 Dec; ():1-10. PubMed ID: 34959236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.